ArticleDrugs & aging2025

Real-World Harm Reduction of Metformin Plus DPP4 Inhibitors versus Metformin Plus Sulfonylureas in Older Adults: A Target Trial Emulation Using German Claims Data.

Paula Starke et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.